Logo

OBN Digital BioTuesday:
'An Insight to the Role of Biobanks in Life Sciences R&D Innovation'

Tuesday 3 November, 17:00 - 18:30

 

OBN Digital BioTuesday:
‘An Insight into the Role of Biobanks in Life Sciences R&D Innovation’

Kindly supported by The Oxford Science Park

 

This BioTuesday event will bring together experts from across the biobanking industry, to share an update on how biobanks have evolved, common goals between partners and the potential impact on future research. 

Biobanks have become a critical resource in medical research and play a crucial role in facilitating access to tissue, blood samples, DNA and data that have helped scientists evolve their understanding of human health and a wide range of serious and life-threatening illnesses.  Events such as the Covid-19 pandemic make the need for such resources very clear. 
 
Through prolonged research and study, biobanking has helped produce treatments for specific diseases including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression, and forms of dementia.

Areas to be addressed:


•             An insight into the work of UK Biobank, the national and international resource funded by the MRC and the Wellcome Trust
 
•             The role of biobanks during the COVID-19 pandemic, from both an epidemiology and treatment perspective

•             The role of the UK Clinical Research Collaboration (UKCRC) Partner, in supporting collaboration in the UK clinical research environment
 
•             The role of the Health Research Authority and the Research Ethics Committees in ensuring the ethical and regulatory compliance of biobanks in the UK, particularly around consent, handling, and future access to samples
 
•             Advice for researchers planning to work with a biobank, what ethical approval they may need and what barriers they may face?
 
•             Insight into virtual biobanks, developed to assist investigators in locating biospecimens for testing and data mining from multiple biobanks in dispersed locations

•             The role that the NHS play in recruiting patients to join study cohorts, and the benefit this offers to UK Biobanks


Agenda:

17:00 - Welcome
          Emma Palmer-Foster, Strategic Communications Consultant, The Oxford Science Park
17:05 - Keynote 1
          Naomi Allen, Professor of Epidemiology at Nuffield Department of Population Health, University of Oxford
17:25 - Keynote 2
          Catherine Blewett, Senior Development Manager at HRA, NHS
17:45 - Case Study
          Morag McFarlane, CEO, & Fiona MacKenzie, Client Services Director, at Tissue Solutions

18:05 - Audience Q&A
18:15 - Networking


About the event:

This session will be run in a live format, with registration open for both OBN Members and Non-Members.  

A live Q&A will follow the keynote presentations and audience members will be encouraged to engage with hosts regarding their thoughts on the topic, and any personal experiences.

There will also be an opportunity to network with registered delegates after the Q&A 
with OBN's virtual networking platform - Remo. Details will be sent upon registration.

OBN Members - Complimentary
Non-Members - £25+VAT


This digital event is kindly supported by:

The Oxford Science Park is one of the most influential science, technology and business environments in the UK for more than 2,500 people in over 70 companies, ranging from start-ups to SMEs and multi-national organisations. It was created in 1991 and is owned and managed by Magdalen College Oxford, one of Oxford’s oldest and most famous colleges with a tradition of academic excellence and entrepreneurship. The Park continues to uphold the College’s heritage. People who work here enjoy 75 acres of beautifully landscaped grounds and an atmosphere of discovery, innovation and entrepreneurship.

Processing. Please wait.
Loading...